ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,707Medicare Part D Prescriptions Filled, Including Refills

Rank: 67 out of 288

$591K Total Retail Price of All Prescriptions

Rank: 46 out of 288

476 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 476 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

5% of this provider’s 476 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 9,979 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 576 528 1 1
LEVOTHYROXINE SODIUM 569 525 2 2
OMEPRAZOLE 427 391 3 3
ATENOLOL 335 322 4 10
LISINOPRIL 312 301 5 4
AMLODIPINE BESYLATE 301 293 6 6
METOPROLOL TARTRATE 236 232 7 8
FUROSEMIDE 209 191 8 5
HYDROCHLOROTHIAZIDE 206 195 9 13
WARFARIN SODIUM 194 152 10 9
METOPROLOL SUCCINATE 187 186 11 15
LOSARTAN POTASSIUM 165 158 12 16
ATORVASTATIN CALCIUM 161 153 13 14
POLYETHYLENE GLYCOL 3350 155 154 14 38
GABAPENTIN 152 144 15 17
METFORMIN HCL 152 138 15 12
CITALOPRAM HBR 152 135 15 18
CRESTOR 148 132 18 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 141 128 19 34
FLUTICASONE PROPIONATE 128 121 20 41
ALENDRONATE SODIUM 125 109 21 20
POTASSIUM CHLORIDE 123 116 22 11
GLIMEPIRIDE 121 115 23 32
SPIRONOLACTONE 116 104 24 36
PRAVASTATIN SODIUM 114 114 25 21
ALLOPURINOL 112 96 26 23
RANITIDINE HCL 112 104 26 33
TRAMADOL HCL 111 101 28 19
PAROXETINE HCL 103 103 29 54
ADVAIR DISKUS 94 85 30 50
LOSARTAN-HYDROCHLOROTHIAZIDE 92 89 31 55
SERTRALINE HCL 92 89 31 25
LANTUS 92 87 31 31
CLOPIDOGREL 89 89 34 47
HYDROCODONE-ACETAMINOPHEN 88 88 S3 35 7
ISOSORBIDE MONONITRATE ER 86 84 36 35
PREDNISONE 81 79 37 30
TAMSULOSIN HCL 79 67 38 24
SPIRIVA 77 66 39 48
CARVEDILOL 74 69 40 27
AMITRIPTYLINE HCL 73 73 R 41 65
NAMENDA 72 72 42 39
NOVOLOG 71 71 43 91
PANTOPRAZOLE SODIUM 63 54 44 42
CIPROFLOXACIN HCL 62 60 45 62
BENAZEPRIL HCL 61 58 46 52
INSULIN SYRINGE 58 55 47 79
VENLAFAXINE HCL 58 48 47 273
DILTIAZEM 24HR CD 55 55 49 75
CYCLOBENZAPRINE HCL 53 46 R 50 73
OXYBUTYNIN CHLORIDE 53 53 50 69
TRIAMTERENE-HCTZ 52 51 52 28
ZOLPIDEM TARTRATE 51 48 53 22
LOVASTATIN 51 48 53 46
PLAVIX 50 50 55 71
TRAZODONE HCL 50 50 55 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 26, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.